$1.40
-0.01-0.71%
Pre-Market: Apr 4, 4:41 PM EDT
Comments
Loading...
Immuneering Earnings Estimates, EPS & Revenue | NASDAQ:IMRX | Benzinga
Immuneering reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 6
EPS Estimate
$-0.410
Quarterly Revenue Estimate
–
Annual Revenue
(as of Dec 31)
(as of Dec 31)
–
Analyze the earnings history of Immuneering using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IMRX | Immuneering | -$0.49 | -$0.41 | — | — | $0.00 | — | — | — | 05/06/2025 | Get Alert |
| IMRX | Immuneering | -$0.52 | -$0.47 | -$0.58 | -23.40% | $0.00 | — | $0.00 | — | 03/20/2025 | Get Alert |
| IMRX | Immuneering | -$0.43 | -$0.55 | -$0.49 | 10.91% | $0.00 | — | $0.00 | — | 11/13/2024 | Get Alert |
| IMRX | Immuneering | -$0.43 | -$0.52 | -$0.47 | 9.62% | $0.00 | — | $0.00 | — | 08/06/2024 | Get Alert |
| IMRX | Immuneering | -$0.51 | -$0.46 | -$0.49 | -6.52% | $0.00 | — | $0.00 | — | 05/07/2024 | Get Alert |
| IMRX | Immuneering | -$0.50 | -$0.47 | -$0.52 | -10.64% | $456.00 | — | $0.00 | — | 03/01/2024 | Get Alert |
| IMRX | Immuneering | -$0.49 | -$0.49 | -$0.43 | 12.24% | $38.38K | — | $0.00 | — | 11/09/2023 | Get Alert |
| IMRX | Immuneering | -$0.44 | -$0.53 | -$0.43 | 18.87% | $94.42K | — | $0.00 | — | 08/03/2023 | Get Alert |
| IMRX | Immuneering | -$0.49 | -$0.56 | -$0.51 | 8.93% | $183.70K | $10.00K | $0.00 | -100.00% | 05/04/2023 | Get Alert |
| IMRX | Immuneering | -$0.42 | -$0.58 | -$0.50 | 13.79% | $189.59K | $60.00K | $456.00 | -99.24% | 03/06/2023 | Get Alert |
| IMRX | Immuneering | -$0.47 | -$0.49 | -$0.49 | 0.00% | $482.83K | $150.00K | $38.38K | -74.41% | 11/10/2022 | Get Alert |
| IMRX | Immuneering | -$1.61 | -$0.52 | -$0.44 | 15.38% | $660.04K | $180.00K | $94.42K | -47.55% | 08/10/2022 | Get Alert |
| IMRX | Immuneering | -$1.26 | — | -$0.49 | — | $748.20K | — | $183.70K | — | 05/10/2022 | Get Alert |
| IMRX | Immuneering | -$1.18 | -$0.39 | -$0.42 | -7.69% | $665.08K | $560.00K | $189.59K | -66.14% | 03/10/2022 | Get Alert |
| IMRX | Immuneering | -$0.89 | -$0.57 | -$0.47 | 17.54% | $682.57K | $650.00K | $482.83K | -25.72% | 11/09/2021 | Get Alert |
| IMRX | Immuneering | -$0.73 | -$1.48 | -$1.61 | -8.78% | $480.80K | $330.00K | $660.04K | 100.01% | 09/09/2021 | Get Alert |
Immuneering (IMRX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-20 | $-0.58 | $-0.47 | -23.4 % |
| Q3 | 2024-11-13 | $-0.49 | $-0.55 | 10.9 % |
| Q2 | 2024-08-06 | $-0.47 | $-0.52 | 9.62 % |
| Q1 | 2024-05-07 | $-0.49 | $-0.46 | -6.52 % |
Immuneering (IMRX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | 2023-05-04 | $0 | $10.00K | -100.0 % |
| Q4 | 2023-03-06 | $456.00 | $60.00K | -99.2 % |
| Q3 | 2022-11-10 | $38.38K | $150.00K | -74.4 % |
| Q2 | 2022-08-10 | $94.42K | $180.00K | -47.5 % |
FAQ
When is Immuneering (NASDAQ:IMRX) reporting earnings?
Immuneering (IMRX) is scheduled to report earnings on May 6, 2025. The last reported earnings were for reported on March 20, 2025 for Q4.
What were the latest earnings per share (EPS) for Immuneering (NASDAQ:IMRX)?
The Actual EPS was $-0.58, which missed the estimate of $-0.47.
What were Immuneering’s (NASDAQ:IMRX) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.